Influence of lung transplantation on the essential fatty acid profile in cystic fibrosis

Prostaglandins Leukot Essent Fatty Acids. 2020 Jul:158:102060. doi: 10.1016/j.plefa.2020.102060. Epub 2020 Jan 23.

Abstract

Lung transplantation is assumed to normalize essential fatty acid (EFA) profile in the plasma, described as abnormal in patients with cystic fibrosis (CF). This study sought to evaluate the EFA profile in both the plasma and erythrocyte membrane according to lung status by comparing CF patients with or without a lung transplant. A total of 50 homozygous F508del patients (33 CF patients [CF group] and 17 CF patients with a lung transplant [TX CF group]) were included. In comparison with the CF group, in the plasma, the levels of total n-3, α-linolenic, eicosapentaenoic, and docosahexaenoic acids were higher and the n-6/n-3 ratio was lower in the TX CF group. Yet, these differences were not observed in the erythrocyte membrane. This study supports that lung transplantation improves the EFA profile in the plasma but not in the erythrocyte membrane by means of the different mechanisms suggested in this article.

Keywords: Cystic fibrosis; Essential fatty acid; Lung transplantation; Polyunsaturated fatty acids.

Publication types

  • Comparative Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cystic Fibrosis / blood*
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / surgery
  • Erythrocyte Membrane / chemistry*
  • Fatty Acids, Essential / analysis*
  • Fatty Acids, Essential / blood
  • Female
  • Homozygote
  • Humans
  • Lung Transplantation / adverse effects*
  • Male
  • Plasma / chemistry*
  • Prospective Studies
  • Young Adult

Substances

  • Fatty Acids, Essential